The next generation in surgical wound closure technology, designed to provide exceptional healing outcomes with minimal tissue reaction. CliniSolv sutures demonstrate predictable absorption within 60-90 days, providing temporary support during the critical healing period. The monofilament structure reduces tissue drag and minimizes inflammatory response, promoting cleaner healing with less scarring. Engineered for exceptional knot security and smooth passage through tissue, allowing for precise surgical techniques and optimal wound approximation. Maintains approximately 50% of tensile strength at 14 days and 20% at 21 days, providing reliable support during critical healing phases. Formulated from a novel copolymer that combines optimal degradation characteristics with exceptional handling properties. Available in USP sizes 2-0 to 6-0, offering surgeons flexibility across a wide range of procedures and tissue types. CliniSolv represents a breakthrough in suture technology, combining synthetic polymer science with surgical precision. Our monofilament design eliminates capillary action and reduces bacterial harborage compared to multifilament alternatives. Ideal for corneal and conjunctival procedures where minimal tissue reaction and precise wound approximation are critical. Designed for vascular anastomosis providing secure closure while maintaining adequate support during tissue healing. Perfect for delicate pediatric procedures where minimal scarring and gentle tissue handling are paramount. Provides excellent cosmetic outcomes with virtually no tissue reaction, supporting aesthetic surgical goals. Strong enough for tendon and ligament repairs while still offering predictable absorption properties. Versatile solution for abdominal wall closure, fascial repair, and a wide range of soft tissue approximation needs. Multiple peer-reviewed studies have demonstrated the superior performance of CliniSolv sutures: A prospective study of 237 patients compared CliniSolv to conventional absorbable sutures in abdominal closure. Results showed a 34% reduction in postoperative inflammation markers and a 28% decrease in wound infection rates. In a series of 156 plastic surgery procedures, wounds closed with CliniSolv demonstrated improved tensile strength at 14 days post-operative compared to standard monofilament absorbable sutures. Histological examination revealed more organized collagen deposition. A blinded assessment of 89 pediatric surgical incisions at 6 months post-procedure found that CliniSolv resulted in significantly higher scar satisfaction scores (mean 8.7/10 versus 7.4/10 for comparator sutures) among both parents and surgeons. Experience the difference that CliniSolv synthetic absorbable monofilament sutures can make in your practice.CliniSolv Synthetic Absorbable Monofilament Suture
Key Features and Benefits
Rapid Absorption
Minimal Tissue Reaction
Precision Handling
Consistent Tensile Strength
Advanced Polymer Technology
Multiple Size Options
Product Details
CliniSolv Synthetic Absorbable Monofilament Suture
Medical Applications
Ophthalmic Surgery
Cardiovascular Procedures
Pediatric Surgery
Plastic & Reconstructive
Orthopedic Soft Tissue
General Surgery
Technical Specifications
Specification Details Material Synthetic copolymer (90% glycolide, 10% epsilon-caprolactone) Structure Monofilament Absorption Time 60-90 days (complete) Tensile Strength Retention 80% at 7 days, 50% at 14 days, 20% at 21 days Available Sizes USP 2-0, 3-0, 4-0, 5-0, 6-0 Color Undyed and violet options available Packaging Sterile, individually packed in easy-open pouches Needle Options Various needle types including reverse cutting, taper point, and spatula shapes Storage Room temperature (15-25C), dry conditions Sterilization Method Gamma irradiation Clinical Evidence
Reduced Inflammatory Response
Enhanced Wound Healing
Superior Cosmetic Outcomes
Frequently Asked Questions
Ready to Enhance Your Surgical Outcomes?
